MS
MRNA icon

Mizuho Securities’s Moderna MRNA Stock Holding History

Mizuho Securities’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-20
Closed -$2K – 155
2022
Q3 		$2K Buy
20
+1
+5% +$152 ﹤0.01% 175
2022
Q2 		$5K Hold
19
– – ﹤0.01% 155
2022
Q1 		$3K Sell
19
-1
-5% -$168 ﹤0.01% 174
2021
Q4 		$5K Hold
20
– – ﹤0.01% 152
2021
Q3 		$8K Sell
20
-23
-53% -$8.48K ﹤0.01% 109
2021
Q2 		$10K Buy
43
+2
+5% +$357 ﹤0.01% 100
2021
Q1 		$5K Buy
+41
New +$5.94K ﹤0.01% 159

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mizuho Securities's MRNA Position: Q4 2022 in Review

Mizuho Securities sold out of Moderna (MRNA) in Q4 2022, closing a stake of 20 shares — an estimated $2K sold.

Mizuho Securities first reported a position in MRNA in Q1 2021 and held it in 7 quarters. The position peaked at $10K in Q2 2021. 1,071 funds tracked by Wall St. Rank hold MRNA as of Q4 2022.

  • Mizuho Securities reported no remaining Moderna position as of Q4 2022 after selling out during the quarter.
  • Mizuho Securities sold 20 Moderna shares in Q4 2022, an estimated $2K.
  • Mizuho Securities first reported a position in Moderna in Q1 2021 and held it in 7 quarters.
  • Mizuho Securities's Moderna position peaked at $10K in Q2 2021.
  • 1,071 funds tracked by Wall St. Rank held Moderna as of Q4 2022.

Based on Mizuho Securities's 13F filing for Q4 2022, filed 7 Feb 2023.